LON:SYNC Syncona Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Syncona Limited Please log in to your account or sign up in order to add this asset to your watchlist. GBX 200.50 -1.00 (-0.50%) (As of 06/27/2022 12:45 PM ET) Add Compare Share Today's Range 200.50▼ 204.5050-Day Range 163.80▼ 21052-Week Range 154▼ 224.50Volume153,073 shsAverage Volume836,869 shsMarket Capitalization£1.34 billionP/E Ratio154.23Dividend Yield1.06%Price TargetGBX 279 ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesOptions Chain View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SYNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNC Stock Forecast (MarketRank)Overall MarketRank™1.67 out of 5 starsAnalyst Opinion: 3.5Community Rank: 4.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 3.5 Analyst's Opinion Consensus RatingSyncona has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 279, Syncona has a forecasted upside of 39.2% from its current price of GBX 200.50.Amount of Analyst CoverageSyncona has received no research coverage in the past 90 days. Previous Next 4.0 Community Rank Outperform VotesSyncona has received 95 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSyncona has received 65 “underperform” votes. (Add your “underperform” vote.)Community SentimentSyncona has received 59.38% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Syncona and other stocks. Vote “Outperform” if you believe SYNC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SYNC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldSyncona pays a meaningful dividend of 1.06%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSyncona does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Syncona insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Syncona is 154.23, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Syncona is 154.23, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 29.45.Price to Book Value per Share RatioSyncona has a P/B Ratio of 1.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Syncona (LON:SYNC)Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.Read More SYNC Stock News HeadlinesJune 17, 2022 | uk.finance.yahoo.comWhat does the future hold for the Syncona share price?June 16, 2022 | lse.co.ukSyncona records slight increase in net asset value, skips dividendMay 18, 2022 | lse.co.ukSyncona invests USD54 million in SwanBio Therapeutics funding roundMay 18, 2022 | proactiveinvestors.comSyncona climbs on back of investment in SwanBioMay 18, 2022 | nz.finance.yahoo.comSwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological ConditionsMay 11, 2022 | lse.co.ukSyncona investee Freeline narrows quarterly loss as costs fallApril 28, 2022 | reuters.comBetting big on drug discovery, UK's OMass Therapeutics raises $100 mlnApril 11, 2022 | lse.co.ukSyncona's investee Anaveon receives good trial dataApril 1, 2022 | lse.co.ukSyncona notes portfolio company Freeline annual loss widens in 2021March 25, 2022 | seekingalpha.comFreeline Therapeutics spikes as Syncona discloses stakeMarch 12, 2022 | lse.co.ukValneva now expects recommendation on COVID-19 vaccine by AprilMarch 11, 2022 | lse.co.ukSyncona to invest further USD20 million in Freeline TherapeuticsMarch 10, 2022 | apnews.comClade Therapeutics Announces the Appointment of Derek Hei, Ph.D., as Chief Technology OfficerSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:SYNC Previous SymbolLON:BACT CUSIPN/A CIKN/A Webwww.bacitltd.com Phone17168531362FaxN/AEmployeesN/AYear FoundedN/ACompany Calendar Today6/27/2022Next Earnings (Estimated)8/03/2022Price Target and Rating Average Stock Price ForecastGBX 279 High Stock Price ForecastGBX 279 Low Stock Price ForecastGBX 279 Forecasted Upside/Downside+39.2%Consensus RatingBuy Rating Score (0-4)3 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio154.23 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.67 Quick Ratio0.67 Sales & Book Value Annual Sales£18.69 million Price / Sales71.51 Cash FlowGBX 0.10 per share Price / Cash Flow1,956.00 Book ValueGBX 197.40 per share Price / Book1.02Miscellaneous Outstanding Shares666,734,000Free FloatN/AMarket Cap£1.34 billion OptionableOptionable BetaN/A Syncona Frequently Asked Questions Should I buy or sell Syncona stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syncona in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Syncona stock. View analyst ratings for Syncona or view top-rated stocks. What is Syncona's stock price forecast for 2022? 2 brokers have issued 12 month target prices for Syncona's stock. Their SYNC stock forecasts range from GBX 279 to GBX 279. On average, they predict Syncona's share price to reach GBX 279 in the next year. This suggests a possible upside of 39.2% from the stock's current price. View analysts' price targets for Syncona or view top-rated stocks among Wall Street analysts. How has Syncona's stock price performed in 2022? Syncona's stock was trading at GBX 212 at the start of the year. Since then, SYNC shares have decreased by 5.4% and is now trading at GBX 200.50. View the best growth stocks for 2022 here. When is Syncona's next earnings date? Syncona is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for Syncona. Who are Syncona's key executives? Syncona's management team includes the following people: Mr. Thomas Henderson, Co-Founder & Non-Exec. Director (Age 56)Dr. Martin Patrick Murphy Ph.D., Chief Exec. Officer (Age 54)Mr. John McDonald, Co-Founder (Age 57)Mr. Rolf Kristian Berndtson Soderstrom ACA, BA, Chief Financial Officer (Age 56)Dr. Christopher J. Hollowood Ph.D., CIO & Managing Partner of Syncona Investment Management Ltd. (Age 47)Ms. Annabel Clay, Head of Investor RelationsMr. Andrew Cossar, Gen. Counsel of Syncona Investment Management Ltd.Ms. Fenella Dernie, Exec. OfficerMr. Edward Eliot Hodgkin DPhil, Sr. Partner (Age 59)Ms. Nikki Padden Ph.D., Head of Fin. at Syncona Investment Management Ltd. Who are some of Syncona's key competitors? Some companies that are related to Syncona include DWS Group GmbH & Co. KGaA (DWS), M&G (MNG), Pershing Square (PSH), Norbord (OSB), Brookfield Infrastructure (BIPC), Investec Group (INVP), F&C Investment Trust (FCIT), Intermediate Capital Group (ICP), Hargreaves Lansdown (HL), RIT Capital Partners (RCP), Greencoat UK Wind (UKW), HICL Infrastructure (HICL), Man Group (EMG), International Public Partnerships (INPP) and The Renewables Infrastructure Group (TRIG). View all of SYNC's competitors. What other stocks do shareholders of Syncona own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include (CELG), Rexahn Pharmaceuticals (REXN), Barrick Gold (ABX), Agnico Eagle Mines (AEM), Franco-Nevada (FNV), Goldex Resources (GDX), VanEck Gold Miners ETF (GDX), Goldcorp (GG), Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK). What is Syncona's stock symbol? Syncona trades on the London Stock Exchange (LON) under the ticker symbol "SYNC." How do I buy shares of Syncona? Shares of SYNC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Syncona's stock price today? One share of SYNC stock can currently be purchased for approximately GBX 200.50. How much money does Syncona make? Syncona (LON:SYNC) has a market capitalization of £1.34 billion and generates £18.69 million in revenue each year. How can I contact Syncona? Syncona's mailing address is Trafalgar Court, Les Banques, PO Box 255, ST PETER PORT, GY1 3QL, Guernsey. The official website for Syncona is www.bacitltd.com. The company can be reached via phone at 17168531362. This page (LON:SYNC) was last updated on 6/27/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
